§ 58-56B-30. (Effective October 1, 2026) Ownership interests in or of the PSAO by drug manufacturers, sellers, or wholesale distributors.
172 words·~1 min read·
/nc/chapter-58/58-56b-30A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
§ 58-56B-30. (Effective October 1, 2026) Ownership interests in or of the PSAO by drug manufacturers, sellers, or wholesale distributors.
(a)Prohibitions. - A PSAO that owns or is owned by, in whole or in part, any entity that manufactures, sells, or distributes prescription drugs, biological products, or medical devices shall not, as a condition of entering into a PSAO-pharmacy contract, require that the independent pharmacy purchase any drugs or medical devices solely from an entity with which the PSAO has an ownership interest or that has an ownership in the PSAO.
(b)Disclosure Requirements. - A PSAO that owns or is owned by, in whole or in part, any entity that manufactures, sells, or distributes prescription drugs, biological products, or medical devices shall disclose to the Department any agreement with an independent pharmacy to purchase prescription drugs, biological products, or medical devices by an independent pharmacy from the PSAO or an entity with which the PSAO has an ownership interest or that has an ownership in the PSAO. (2025-69, s. 2.1.)